Results 191 to 200 of about 576,325 (300)

Novel Vascular‐Adaptive Liquid Metal Microspheres Enable Visualized Arterial Embolization Therapy

Advanced Science, EarlyView.
We present drug‐loaded liquid metal microspheres (X‐MEN) as a novel agent for image‐guided arterial embolization. With inherent radiopacity and superior deformability, X‐MEN enables real‐time monitoring and conforms tightly to irregular vessels. This approach ensures precise, long‐lasting embolization without recanalization, addressing critical ...
Chenyu Shen, Junge Chen, Gang Zhang, Zhusheng Liu, Yichen Wan, Lei Lei, Weiyan Ren, Yanyu Zhao, Bozhang Xia, Zhiqiang Yi, Jinjin Wang, Jingwang Gao, Gen Mu, Xing‐Jie Liang, Zhijun Wang   +14 more
wiley   +1 more source

Survey of Spanish nephrologists' opinion on the applicability of Fried's geriatric frailty criteria in patients with end-stage renal disease. [PDF]

BMC Nephrol
Pérez-Fernández M, McAdams-DeMarco MA, Alonso-Fuente A, López-Ongil S, Tornero-Molina F, Rodríguez-Puyol D, Martínez-Miguel P.   +6 more
europepmc   +1 more source

Beyond Extracellular Vesicle (EV) Hype: Practical Solutions and Remaining Hurdles in EV Research, Manufacturing, and Clinical Translation

Advanced Science, EarlyView.
ABSTRACT Extracellular vesicles (EVs) are nanoscale mediators of intercellular communication with diverse molecular cargoes that reflect their cell of origin. Advances in isolation, detection, and single‐particle analytics have revealed increasing molecular and functional heterogeneity, while exposing limitations in how EV identity and activity are ...
David J. Lundy, Zoe L. Chau, Sheng‐You Chen, Nanami Fujisawa, John J. Hill, Barnett M. Hsu, Joanne K. Liu, Karol W. Mai, James J. Lai   +8 more
wiley   +1 more source

A Multilevel Spatial Survival Analysis of Patients in Texas with End-Stage Renal Disease. [PDF]

Healthcare (Basel)
Kim D, Chun Y, Griffith DA.
europepmc   +1 more source

Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy

Advanced Science, EarlyView.
Cancer immunotherapy faces challenges in predicting treatment responses and understanding resistance mechanisms. Artificial intelligence (AI) and machine learning (ML) offer powerful solutions for cancer immunotherapy in patient stratification, biomarker discovery, treatment strategy optimization, and foundation model development.
Xinchao Wu, Mengtao Sun, Lusheng Li, Jieqiong Wang, Shibiao Wan   +4 more
wiley   +1 more source

Ocular manifestations in end-stage renal disease

The Pan-American Journal of Ophthalmology
Pradeep Kumar Panigrahi, Rahul Bector
doaj   +1 more source

Efficacy of belimumab on extra-renal lupus in patients with lupus nephritis and end-stage renal disease. [PDF]

Front Med (Lausanne)
Teng JQ, Guo WP, Xu J, Tan M, Tan Y, Qu Z, Su HH, Yu F.   +7 more
europepmc   +1 more source

A Circuit of Mechanically Regulated Transcription Factors Balances Regenerative and Fibrotic Memory of Mesenchymal Stromal Cells

Advanced Science, EarlyView.
Producing MSCs on rigid culture substrates induces a scar‐making phenotype, jeapordizing therapeutic success. ‘Tissue‐soft’ surfaces prevent MSC fibrogenesis and preserve regenerative traits. An epigenetic network, driven by HOXA11 and SALL1, maintains ‘soft memory’ by keeping chromatin open in relaxed MSCs, promoting anti‐fibrotic programs.
Fereshteh Sadat Younesi, Andrew E. Miller, Li Diao, Xinying Guo, Natalie Andonian, Elham Karimizadeh, Thomas H. Barker, Boris Hinz   +7 more
wiley   +1 more source

Study on causes of death and influencing factors in hemodialysis patients with End-Stage renal disease. [PDF]

BMC Urol
Huang J, Li Y, Shen S, Yu L, Sun Q.
europepmc   +1 more source

Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome [PDF]

, 2015
Harvey, Erwin, Johnson, Scott, Kincaid, John F, Vande Walle, Johan   +3 more
core   +2 more sources